Abstract
Author response for "The real‐world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes (<scp>TROPHIES</scp>): Final, 24‐month analysis of time to first significant treatment change, treatment persistence and clinical outcomes"
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
